Oncology Medical Head, International

JOB SUMMARY

The Oncology Medical Head, International is the senior Medical Affairs leader accountable for defining and executing the international medical strategy for Pfizer’s Oncology portfolio across the full product lifecycle—from early development through post-approval value optimization. The role serves as a core member of the global Oncology Medical Affairs leadership team and is a strategic partner to the Chief Medical Affairs Officer ( International Commercial Division), Regional Global Study Site and Operations (CD&O), Global Clinical Development, International Commercial, Access, Public Policy and Country Medical organizations to deliver patient-centered, evidence-driven medical impact globally. 

This position combines deep oncology clinical and scientific expertise with enterprise leadership to ensure patient-centered, evidence-driven decisions; consistent interpretation and communication of oncology data; and high-quality medical execution across regions. The Oncology Medical Head, International models Pfizer values and behaviors, scientific integrity, and a strong compliance mindset while building a culture of excellence, inclusion, and continuous improvement.

JOB RESPONSIBILITIES

Duties and responsibilities may be delegated as appropriate; however, the Oncology Medical Head, International retains accountability for outcomes. Responsibilities include, but are not limited to:

A. Oncology Medical Strategy & Lifecycle Leadership

• Own and evolve the international medical strategy for assigned Oncology programs and disease areas, aligned to global Oncology strategy and regional patient needs.
• Translate oncology clinical, translational, and real-world evidence into clear strategic implications for patient outcomes, benefit–risk, and value communication.
• Represent and advocate for the international medical perspective in integrated asset and disease strategies with Global Medical, Clinical Development, Safety, Regulatory, Commercial, and Access/HV&E.
• Ensure the international patient and clinician voice is incorporated into development, lifecycle, and evidence generation plans, including unmet need, treatment pathways, and meaningful outcomes.
•  Define and integrate international needs into the Integrated Evidence and Lifecycle plans, including indication expansion, sequencing/combination strategy, line-of-therapy positioning, and differentiation narrative across international markets.

• Set clear scientific objectives and success metrics for medical plans, ensuring focus, prioritization, and measurable impact.

• Engages and leads interactions with clinical and research leaders (experts) including academicians, clinical physicians, medical directors, directors of pharmacy and other health care professionals aligned with brand medical objectives

• Provides medical expertise in the medical/scientific assessment of potential business development activities and pre-proof of concept compounds being considered for the International Oncology organization
• Influences decisions in the organization of external meetings including advisory boards, congress and symposium as appropriate and seeking active feedback for continuous improvement

B. Scientific Narrative, Data Interpretation & Communication

• Lead the team of international medical scientific experts for assigned assets, ensuring consistency of data interpretation and communication across regions and functions.
• Develop and maintain a clear, credible oncology scientific narrative (including mechanism, clinical evidence, safety profile, and patient value) tailored to different audiences while remaining compliant.
• Partner with internal stakeholders to drive alignment on key medical messages, and proactively resolve scientific ambiguities or disagreements.
• Provide medical oversight for scientific content, training, FAQs, and congress materials to ensure accuracy, balance, and consistency.
• Ensure country-aligned medical input into global brand strategy and execution while safeguarding scientific integrity and separation of roles as required.

C. External Scientific Engagement & Stakeholder Partnerships

• Engage on a peer basis with international and regional oncology experts (academics, investigators, clinicians, pharmacists, and healthcare system leaders) to inform strategy and improve patient care.
• Establish and sustain strategic relationships with independent networks and healthcare-providing entities to co-develop medically appropriate solutions that enhance patient outcomes.
• Lead the strategy for advisory boards, expert panels, and scientific meetings—defining objectives, ensuring high-quality insights, and closing the loop with action and communication.
• Repres